Description
The abstract states that disruption of mCa2+ cycling is implicated in neurodegeneration but doesn’t explain the mechanistic pathways linking calcium dysregulation to neuronal death. Understanding these mechanisms is critical for developing targeted neuroprotective therapies.
Gap type: unexplained_observation Source paper: Mitochondrial calcium exchange in physiology and disease. (2022, Physiol Rev, PMID:34698550)
Resolution criteria
Resolution requires: (1) Mitochondrial dynamics assessment (mitochondrial network morphology by TOM20 imaging, fission/fusion protein levels OPA1/DRP1/MFN1/MFN2) in AD patient-derived neurons or brain tissue vs controls (n>=6 per group), quantifying >=30% difference in fission/fusion balance; (2) Experimental rescue: modulating the identified imbalance (Mdivi-1 for fission, MFN2 overexpression for fusion) reverses mitochondrial dysfunction markers (membrane potential, ROS, ATP) and reduces amyloid or tau pathology by >=30%; (3) Human tissue correlation: mitochondrial dynamics protein levels correlate with AD severity markers (Braak stage, CERAD score) at r>=0.5. Mitochondrial abnormality detection without therapeutic rescue demonstration is insufficient.